載入...
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11—first estimates for clinical translation
BACKGROUND: We have recently shown that treatment of mice with the neutral endopeptidase (NEP) inhibitor phosphoramidon (PA) improves the bioavailability and tumor uptake of biodegradable radiopeptides. For the truncated gastrin radiotracer [(111)In-DOTA]MG11 ([(DOTA)DGlu(10)]gastrin(10–17)), this m...
Na minha lista:
| 發表在: | EJNMMI Res |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755954/ https://ncbi.nlm.nih.gov/pubmed/26882895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-015-0158-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|